Search - tctmd.com

Displaying 141 - 160 of 1343

Sort: Relevancy | Date

News Daily News

研究显示糖尿病患者急性心梗后风险差异很大

L.A. McKeown

May 26, 2016

News Daily News

Un Estudio Revela un Sorprendente Rango de Riesgo Post-IAM entre Pacientes con Diabetes

L.A. McKeown

May 26, 2016

News Daily News

Study Shows Surprising Range of Risk After Acute MI Among Patients With Diabetes

L.A. McKeown

May 26, 2016

News Daily News

The Ups and Downs of Statin Adherence Around Acute MI Hospitalization

Todd Neale

May 25, 2016

News Conference News EuroPCR 2016

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Caitlin E. Cox

May 25, 2016

Presentation

Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus

Presenter: Suzanne V. Arnold

May 25, 2016

News Daily News

Could Biased Medication Prescribing Explain Obesity Paradox in PCI?

L.A. McKeown

May 19, 2016

News Daily News

“Inconvenient and Unsettling”: Substantial Silent MI Rates in the United States Prompt Questions for Screening

Yael L. Maxwell

May 16, 2016

News Daily News

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Yael L. Maxwell

May 13, 2016

News Conference News SCAI 2016

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

L.A. McKeown

May 13, 2016

News Daily News

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

Yael L. Maxwell

May 13, 2016

News Daily News

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Yael L. Maxwell

May 13, 2016

News Daily News

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Caitlin E. Cox

May 12, 2016

Presentation

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Presenter: Ambarish Pandey

May 12, 2016

News Conference News SCAI 2016

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

L.A. McKeown

May 11, 2016

News Industry News

Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes

May 06, 2016

News Daily News

El Debate Sigue Abierto: ¿Sobrevalora la Calculadora de la Enfermedad Cardiovascular Aterosclerótica el Riesgo de los Pacientes?

Yael L. Maxwell

May 04, 2016

News Daily News

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

Yael L. Maxwell

May 04, 2016

News Industry News

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

May 04, 2016

News Daily News

One-Year Survival Similar after MI With or Without Out-of-Hospital Cardiac Arrest

Leah Lawrence

April 27, 2016

Advertisement

研究显示糖尿病患者急性心梗后风险差异很大

Un Estudio Revela un Sorprendente Rango de Riesgo Post-IAM entre Pacientes con Diabetes

Study Shows Surprising Range of Risk After Acute MI Among Patients With Diabetes

The Ups and Downs of Statin Adherence Around Acute MI Hospitalization

Sex Disparities in MI Care Are Narrowing, but There’s Still a Long Way to Go

Predicting Adverse Outcomes After Myocardial Infarction Among Patients With Diabetes Mellitus

Could Biased Medication Prescribing Explain Obesity Paradox in PCI?

“Inconvenient and Unsettling”: Substantial Silent MI Rates in the United States Prompt Questions for Screening

尽管有指南说明，但糖尿病患者多支 CAD 患者接受 PCI 的人数仍多于 CABG

Risk-Treatment Paradox Unfortunately Alive and Well Among Young Women with ACS

Guidelines Notwithstanding, More Diabetics with Multivessel CAD Receive PCI Than CABG

A Pesar de las Directrices, Más Diabéticos con EAC Multivaso son sometidos a PCI que a CABG

Treatment Duration May Explain Inconsistent Risks Seen With Testosterone Therapy

Revascularization Trends in Pts with Diabetes and Multivessel CAD Presenting with NSTEMI

Gender and TAVR: Studies Highlight Different Outcomes Between Men and Women

Intarcia Announces Successful Cardiovascular Safety Results in Phase 3 FREEDOM-CVO Trial for ITCA 650, an Investigational Therapy for Type 2 Diabetes

El Debate Sigue Abierto: ¿Sobrevalora la Calculadora de la Enfermedad Cardiovascular Aterosclerótica el Riesgo de los Pacientes?

Does the Atherosclerotic Cardiovascular Disease Calculator Overestimate Patient Risk? The Debate Continues

BIOTRONIK Announces FDA Approval of MR Conditional Cardiac Resynchronization Defibrillators

One-Year Survival Similar after MI With or Without Out-of-Hospital Cardiac Arrest

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content